This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Pablo Umana - Innovator in Antibody Technology
Introduction
Pablo Umana is a distinguished inventor based in Zurich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. His work has the potential to impact various medical applications, enhancing treatment options for patients.
Latest Patents
Pablo Umana holds a patent for "Trivalent, bispecific antibodies." This invention relates to the creation of trivalent, bispecific antibodies, methods for their production, pharmaceutical compositions containing these antibodies, and their various uses. His patent represents a significant advancement in antibody technology, showcasing his expertise in this area.
Career Highlights
Umana is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in biotechnology.
Collaborations
Throughout his career, Pablo has worked alongside notable colleagues, including Ulrich Brinkmann and Rebecca Croasdale. These collaborations have fostered an environment of innovation and have led to the advancement of various projects within the company.
Conclusion
Pablo Umana's contributions to the field of biotechnology, particularly through his patent on trivalent, bispecific antibodies, highlight his role as a key innovator. His work at Hoffmann-La Roche Inc. and collaborations with esteemed colleagues further emphasize his impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile